Insider Transactions by Parschauer Karah Herdman

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and Chief Legal OfficerMar 01, 2024Sale$53.763,756201,92367,340Mar 05, 2024, 08:22 PM
EOLSEvolus, Inc.Parschauer Karah HerdmanDirectorJan 30, 2024Sale$13.1411,931156,73331,243Feb 02, 2024, 04:57 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and Chief Legal OfficerMay 04, 2023Sale$45.004,378197,01051,982May 05, 2023, 02:16 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and Chief Legal OfficerMar 01, 2023Sale$45.253,161143,03556,139Mar 03, 2023, 07:59 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and Chief Legal OfficerMar 07, 2022Sale$62.955,140323,56334,438Mar 08, 2022, 12:25 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and Chief Legal OfficerMar 01, 2022Sale$66.622,886192,26525,472Mar 03, 2022, 06:08 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselOct 14, 2021Sale$81.1431025,15328,358Oct 18, 2021, 06:46 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselSep 08, 2021Sale$77.5814,6721,138,18036,004Sep 09, 2021, 06:22 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMay 06, 2021Sale$113.6731335,57929,997May 10, 2021, 06:13 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMar 01, 2021Sale$138.173,970548,53530,227Mar 03, 2021, 08:47 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselOct 30, 2020Sale$77.3119,8061,531,20233,871Nov 02, 2020, 05:05 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselOct 28, 2020Sale$77.2519414,98724,065Oct 30, 2020, 05:28 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselOct 14, 2020Sale$88.0032528,60023,968Oct 16, 2020, 07:21 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselOct 08, 2020Option Exercise$74.7520,0001,495,00034,293Oct 13, 2020, 05:53 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselOct 06, 2020Option Exercise$69.2220,0001,384,30034,293Oct 07, 2020, 02:57 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselSep 23, 2020Option Exercise$66.7220,0001,334,30034,293Sep 24, 2020, 04:47 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselAug 17, 2020Option Exercise$73.2622,3701,638,88436,663Aug 19, 2020, 02:12 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 20, 2020Option Exercise$78.2264950,76526,663Jun 22, 2020, 01:46 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMay 18, 2020Sale$74.712,722203,37427,312May 19, 2020, 07:12 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMay 06, 2020Option Exercise$66.2624816,43229,904May 08, 2020, 08:02 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselApr 19, 2020Option Exercise$58.5724814,52530,152Apr 21, 2020, 03:36 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMar 01, 2020Option Exercise$56.082,118118,77730,400Mar 03, 2020, 08:00 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 20, 2019Option Exercise$63.4864941,19920,365Jun 24, 2019, 09:16 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 21, 2019Sale$63.011,48993,82218,876Jun 24, 2019, 09:16 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 24, 2019Sale$61.501,22675,39917,650Jun 24, 2019, 09:16 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselApr 29, 2019Sale$68.3046831,96419,580Apr 30, 2019, 06:32 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselApr 19, 2019Option Exercise$64.4324815,97920,048Apr 23, 2019, 06:26 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMar 05, 2019Sale$65.5288658,05120,296Apr 17, 2019, 05:52 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMar 01, 2019Option Exercise$67.5586058,09320,321Mar 04, 2019, 12:00 AM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselAug 21, 2018Option Exercise$66.5110,000665,15019,181Oct 09, 2018, 04:25 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselAug 21, 2018Sale$78.535,000392,6509,181Aug 21, 2018, 06:59 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 21, 2018Sale$82.771,226101,47614,181Jun 21, 2018, 05:32 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 20, 2018Option Exercise$85.3164955,36615,407Jun 20, 2018, 07:18 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMay 10, 2018Sale$60.001,46587,90016,056May 10, 2018, 05:07 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselMar 01, 2018Option Exercise$48.432059,92816,090Mar 05, 2018, 04:22 PM
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP and General CounselJun 20, 2017Option Exercise$63.3870544,6838,795Jun 21, 2017, 04:23 PM